phase readout
saveNCT07505836: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Sinovac Biotech Co., Ltd. Phase: PHASE3. Conditions: Epidemic Meningitis, Meningococcal Vaccines
view source ↗
comments(0)
5-min edit window · permanent after that